GMP Manufacturer of Veterinary Medicine CAS 115550-35-1 Marbofloxacin

• Customization: Available
• Varieties: Antibiotic
• Component: Chemical Synthetic Drugs
• Model NO.: Marbofloxacin CAS 115550-35-1
• Type: The Third Class
• Storage Method: Inert Atmosphere, 2-8°c
• Appearance: Light Yellow, Crystalline Powder
• Product Name: Marbofloxacin
• Assay: 99%
• Stock: in Stock
• Molecular Mass: 362.36
• Molecular Formula: C17h18fno3s
• CAS: 115550-35-1
• Delivery Time: 3-7 Working Days
• Transport Package: 25kg/Drum; 20kg/Drum
• Specification: USP; EP; In-house
• Trademark: QINGMEI
• Origin: China
• Production Capacity: 500000kg/Year

Product Description

Product Description

 

Marbofloxacin is a fluoroquinolone antibiotic that is active against P. multocida in vitro (MIC = 0.016 μg/ml). It exhibits broad-spectrum antibacterial activity mediated by the inhibition of DNA gyrase, with MIC values ranging from 0.016 to 0.4 and 0.19 to 1.7 μg/ml against various Gram-negative and Gram-positive bacterial isolates, respectively. In vivo, the administration of marbofloxacin (2 mg/kg, i.m.) after infection prevents the formation of pulmonary lesions in a bovine calf model of M. haemolytica A1 pneumonia. Oral marbofloxacin (2 mg/kg per day) also exhibits antileishmanial activity in a canine model of leishmaniasis, decreasing parasitic load by 72%. Formulations containing marbofloxacin have been used in the veterinary treatment of bacterial infections.

 

Product Parameters

 

Marbofloxacin Specification
 

Item	Specification	Result
Character	Light yellow, crystalline powder	Complies
	Slightly soluble in water, sparing soluble or slightly soluble in methylene chloride, very slightly soluble in ethanol.	Complies
Identification	IR spectra is consistent with CRS.	Complies
Absorbance	≤0.20	0.08
Related substance	Impurity A      ≤0.1%	Not detected
	Impurity B      ≤0.1%	Not detected
	Impurity C      ≤0.2%	0.09%
	Impurity D      ≤0.2%	Not detected
	Impurity E      ≤0.2%	Not detected
	Any other impurities ≤ 0.2%	Not detected
	Total impurities      ≤0.5%	0.09%
Loss on drying	≤0.5%	0.06%
Sulphated ash	≤0.1	0.05%
Heavy metals	≤20ppm	<20ppm
Assay	99.0%-101.0% on anhydrous basis	99.7%

 

application

 

Mabofloxacin is a novel fluoroquinolone antimicrobial agent, which inhibits the growth of bacteria by inhibiting the DNA transcriptase of bacteria, and has antimicrobial effect on Gram-negative bacteria, Gram-positive bacteria and mycoplasma.
Mabofloxacin can be well absorbed by oral administration and injection, and its toxic and side effects are low.
Mabofloxacin is used for respiratory tract, digestive tract, urinary tract and skin infections caused by sensitive bacteria in cattle, pigs, dogs and cats. It is also effective for bovine and sheep mastitis and porcine mastitis - uteritis - agalactia syndrome.

Packaging & Shipping

 

 

mode of transportation
By Air	By Express	By Sea
suitable for >50	suitable for sampple order or <50	suitable for >300
Fast:3-7 days	Fast:3-10 days	Fast: 7-45 days
lower than the express cost	high shipping cost	lowest cost

 

Company Profile

 

 

Qingdao Qingmei Biotech Co., Ltd is a pharmaceutical company, which is to expand international business and strategic cooperation with Contract Manufacturing on Supplements(Hard Capsules, Softgels, Powders, Sachet), Active Ingredients for Human Health and Animal Health, Herbal Extracts, Food Additives, Feed Additives, Vitamins, Amino Acids, Minerals, Cosmetics raw materials, Pet Medicines, Disinfectant, Farming and Fishery Industry.

The company is located in the beautiful coastal city of Qingdao, near City Hall and the May Fourth Square, and also close to the port, so that it has convenient traffic conditions for trade. The company's business focuses on the development and promotion of the pharmaceutical chemicals, animal health, food additives, plant extracts, cosmetic raw materials, intermediates and other fine chemicals. Production in Qingmei is in accordance with GMP standards, and files are compiled and registered in regulated market to ensure smooth supply channels. Guided by the market development, Qingmei works hard to cover more customers.
 

Our products are approved by cGMP, CEP/COS, FDA, TGA, EUGMP, FAMI-QS and also Halal, Kosher etc.

Our products are widely sold to regions of Asia, Africa, Europe, Latin America, and long-term stable cooperative relations have been established with merchants from hundreds of countries and regions with our cooperation agencies in Turkey, South Africa, Indonesia, Russia, Brazil, Canada and the United States working stably. We are looking forward to making progress together with you!

 

FAQ

 

1:Can I get some samples before bulk order?
Most products provide free samples, but the shipping cost be paid by customers.

2: What's your MOQ?
For the high value product, our MOQ starts from 10g,100g and 1kg.

3: Which kind of payment terms do you accept?
PI will be sent first after confirmation of order,enclosed our bank information.Payment by T/T, Western Union, L/C.

4.How to place an order?
You can contact me through Trademanager, WhatsApp, Skype Online and other contact methods, tell me the product and quantity you need, and then we will give you a quote. If you choose one of the above payment methods, we will arrange the delivery for you.

5:How about your delivery time?
A: Generally, it will take 5 to 7 days after receiving your advance payment.

6:How do you treat quality complaint?
A:First of all, our quality control will reduce the quality problem to near zero. If there is a real quality problem caused by us, we will send you free goods for replacement or refund your loss.
 

We support the below registration services:
 

1, Argentinian National Institute of Drugs
Instituto Nacional de Medicamentos (INAME)

2, AustralianTherapeuticGoodsAdministration (TGA)

3, Belgian Federal Agency for Medicines and Health Products
Agence Fédérale des Médicaments et des Produits de Santé(AFMPS)
Federaal Agentschap voor Geneesmiddelen enGezondheidsproducten (FAGG)

4, CanadianHealthProducts andFoodBranchInspectorate(HPFBI)

5, TaiwanFood andDrugAdministration(TFDA)

7, Czech State Institute for Drug Control
Státní Ústav pro Kontrolu Léčiv (SÚKL)

8, CzechInstitute forStateControl ofVeterinaryBiologicalsandMedicines (ISCVBM)

9, DanishHealth andMedicinesAuthority (DHMA)

10, FinnishMedicinesAgency (FIMEA)

11, French National Agency for Medicines and Health Products Safety
Agence nationale de sécurité du médicament et des produits de santé (ANSM)

12, French Agency for Food, Environmental & Occupational Health Safety

Agence nationale de sécurité sanitaire de l'alimentation, de l'environnement et du travail (ANSES)

13, German Federal Ministry of Health * 
Bundesministerium für Gesundheit (BMG)

14, IcelandicMedicinesAgency(IMA)

20, IndonesianNationalAgency forDrug andFoodControl (NADFC)

21, HealthProductsRegulatoryAuthority(HPRA)

22, Italian Medicines Agency 
Agenzia Italiana del Farmaco (AIFA)

23, JapanesePharmaceuticals andMedicalDevicesAgency(PMDA) 

24, Korea (Republic of)Ministry ofFood andDrugSafety(MFDS)

25, MalaysianNationalPharmaceuticalControlBureau(NPCB)

26, Dutch Health Care Inspectorate*   
Inspectie voor de Gezondheidszorg (IGZ)

27, New Zealand's Medicines and Medical Devices Safety Authority (Medsafe)

28, NorwegianMedicinesAgency(NOMA)

29, PolishMainPharmaceuticalInspectorate (MPI)

30, RomanianNationalAgency forMedicines andMedicalDevices (NAMMD)

31, South AfricanMedicinesControlCouncil(MCC)

32, Spanish Agency of Medicines and Medical Devices*

Agencia Española de Medicamentos y Productos Sanitarios(AEMPS)

33, SwedishMedicalProductsAgency(MPA)

34, United Kingdom'sMedicines andHealthcareProductsRegulatoryAgency(MHRA)

35, United Kingdom'sVeterinaryMedicineDirectorate (VMD)

36, U.S.Food andDrugAdministration (US FDA)

37, European Directorate for the Quality of Medicines & HealthCare (EDQM)

38, European Medicines Agency(EMA)

39, World Health Organization(WHO)